Literature DB >> 22986430

Sepsis-associated encephalopathy.

Teneille E Gofton1, G Bryan Young.   

Abstract

Sepsis-associated encephalopathy (SAE) is a diffuse brain dysfunction that occurs secondary to infection in the body without overt CNS infection. SAE is frequently encountered in critically ill patients in intensive care units, and in up to 70% of patients with severe systemic infection. The severity of SAE can range from mild delirium to deep coma. Seizures and myoclonus are infrequent and cranial nerves are almost always spared, but most severe cases have an associated critical illness neuromyopathy. Development of SAE probably involves a number of mechanisms that are not mutually exclusive and vary from patient to patient. Substantial neurological and psychological morbidities often occur in survivors. Mortality is almost always due to multiorgan failure rather than neurological complications, and is almost 70% in patients with severe SAE. Further research into the pathophysiology, management and prevention of SAE is needed. This Review discusses the epidemiology and clinical presentation of SAE. Recent evidence for SAE pathophysiology is outlined and a diagnostic approach to patients with this syndrome is presented. Lastly, prognosis and management of SAE is discussed.

Entities:  

Mesh:

Year:  2012        PMID: 22986430     DOI: 10.1038/nrneurol.2012.183

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  83 in total

Review 1.  The EEG in metabolic encephalopathy and coma.

Authors:  Peter W Kaplan
Journal:  J Clin Neurophysiol       Date:  2004 Sep-Oct       Impact factor: 2.177

Review 2.  Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  E F M Wijdicks; A Hijdra; G B Young; C L Bassetti; S Wiebe
Journal:  Neurology       Date:  2006-07-25       Impact factor: 9.910

3.  Routine use of the confusion assessment method for the intensive care unit: a multicenter study.

Authors:  Maarten M van Eijk; Mark van den Boogaard; Rob J van Marum; Paul Benner; Piet Eikelenboom; Marina L Honing; Ben van der Hoven; Janneke Horn; Gerbrand J Izaks; Annette Kalf; Attila Karakus; Ine A Klijn; Michael A Kuiper; Frank-Erik de Leeuw; Tjarda de Man; Roos C van der Mast; Robert-Jan Osse; Sophia E de Rooij; Peter E Spronk; Peter H van der Voort; Willem A van Gool; Arjen J Slooter
Journal:  Am J Respir Crit Care Med       Date:  2011-05-11       Impact factor: 21.405

4.  Validation of a new coma scale: The FOUR score.

Authors:  Eelco F M Wijdicks; William R Bamlet; Boby V Maramattom; Edward M Manno; Robyn L McClelland
Journal:  Ann Neurol       Date:  2005-10       Impact factor: 10.422

5.  Continuous electroencephalography in the medical intensive care unit.

Authors:  Mauro Oddo; Emmanuel Carrera; Jan Claassen; Stephan A Mayer; Lawrence J Hirsch
Journal:  Crit Care Med       Date:  2009-06       Impact factor: 7.598

6.  Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure.

Authors:  David Brealey; Sekhar Karyampudi; Thomas S Jacques; Marco Novelli; Ray Stidwill; Val Taylor; Ryszard T Smolenski; Mervyn Singer
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2003-11-06       Impact factor: 3.619

7.  E. coli peritonitis and bacteremia cause increased blood-brain barrier permeability.

Authors:  G C du Moulin; D Paterson; J Hedley-Whyte; S A Broitman
Journal:  Brain Res       Date:  1985-08-12       Impact factor: 3.252

8.  Septic encephalopathy. Evidence for altered phenylalanine metabolism and comparison with hepatic encephalopathy.

Authors:  B A Mizock; H C Sabelli; A Dubin; J I Javaid; A Poulos; E C Rackow
Journal:  Arch Intern Med       Date:  1990-02

9.  The effects of riluzole on neurological, brain biochemical, and histological changes in early and late term of sepsis in rats.

Authors:  Hale Z Toklu; Meral Keyer Uysal; Levent Kabasakal; Serap Sirvanci; Feriha Ercan; Mehmet Kaya
Journal:  J Surg Res       Date:  2008-04-09       Impact factor: 2.192

10.  Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group.

Authors:  C L Sprung; P N Peduzzi; C H Shatney; R M Schein; M F Wilson; J N Sheagren; L B Hinshaw
Journal:  Crit Care Med       Date:  1990-08       Impact factor: 7.598

View more
  166 in total

1.  Expert consensus on the perioperative management of patients with sepsis.

Authors:  Jun-Ping Chen; Xiang-Ming Fang; Xiao-Ju Jin; Rong-Tian Kang; Ke-Xuan Liu; Jin-Bao Li; Yan Luo; Zhi-Jie Lu; Chang-Hong Miao; Han-Xiang Ma; Wei Mei; Yang-Wen Ou; Si-Hua Qi; Zai-Sheng Qin; Guo-Gang Tian; An-Shi Wu; Dong-Xin Wang; Tian Yu; Yong-Hao Yu; Jing Zhao; Ming-Zhang Zuo; Shi-Hai Zhang
Journal:  World J Emerg Med       Date:  2015

2.  Neurotoxic Concentration of Piperacillin during Continuous Infusion in Critically Ill Patients.

Authors:  Marie-Charlotte Quinton; Sandra Bodeau; Loay Kontar; Yoann Zerbib; Julien Maizel; Michel Slama; Kamel Masmoudi; Anne-Sophie Lemaire-Hurtel; Youssef Bennis
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

3.  Neuropeptide downregulation in sepsis.

Authors:  Fabiano Pinheiro da Silva; Marcel Cerqueira César Machado; Paulo Clemente Sallet; Fernando Godinho Zampieri; Alessandra Carvalho Goulart; Francisco Torggler Filho; Hermes Vieira Barbeiro; Irineu Tadeu Velasco; Luiz Monteiro da Cruz Neto; Heraldo Possolo de Souza
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

Review 4.  New insights in the systemic and molecular underpinnings of general anesthetic actions mediated by γ-aminobutyric acid A receptors.

Authors:  Bernd Antkowiak; Uwe Rudolph
Journal:  Curr Opin Anaesthesiol       Date:  2016-08       Impact factor: 2.706

5.  Serum S100β is a better biomarker than neuron-specific enolase for sepsis-associated encephalopathy and determining its prognosis: a prospective and observational study.

Authors:  Bo Yao; Li-Na Zhang; Yu-Hang Ai; Zhi-Yong Liu; Li Huang
Journal:  Neurochem Res       Date:  2014-04-24       Impact factor: 3.996

6.  Sepsis-associated encephalopathy.

Authors:  Dario-Lucas Helbing; Leopold Böhm; Otto W Witte
Journal:  CMAJ       Date:  2018-09-10       Impact factor: 8.262

7.  P2X7 Receptor Signaling Contributes to Sepsis-Associated Brain Dysfunction.

Authors:  Luiz Eduardo Baggio Savio; Mariana G Juste Andrade; Paola de Andrade Mello; Patrícia Teixeira Santana; Aline Cristina Abreu Moreira-Souza; Janaína Kolling; Aline Longoni; Linda Feldbrügge; Yan Wu; Angela T S Wyse; Simon C Robson; Robson Coutinho-Silva
Journal:  Mol Neurobiol       Date:  2016-10-11       Impact factor: 5.590

8.  Targeting inflammatory monocytes in sepsis-associated encephalopathy and long-term cognitive impairment.

Authors:  Graciela Andonegui; Erin L Zelinski; Courtney L Schubert; Derrice Knight; Laura A Craig; Brent W Winston; Simon C Spanswick; Björn Petri; Craig N Jenne; Janice C Sutherland; Rita Nguyen; Natalie Jayawardena; Margaret M Kelly; Christopher J Doig; Robert J Sutherland; Paul Kubes
Journal:  JCI Insight       Date:  2018-05-03

9.  Systemic Lipopolysaccharide Administration-Induced Cognitive Impairments are Reversed by Erythropoietin Treatment in Mice.

Authors:  Rong Gao; Yuan-hui Tang; Jian-hua Tong; Jian-Jun Yang; Mu-huo Ji; Si-hai Zhu
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

10.  Brain-Defective Insulin Signaling Is Associated to Late Cognitive Impairment in Post-Septic Mice.

Authors:  Fernanda S Neves; Patrícia T Marques; Fernanda Barros-Aragão; José Bruno Nunes; Aline M Venancio; Danielle Cozachenco; Rudimar L Frozza; Giselle F Passos; Robson Costa; Jade de Oliveira; Daiane F Engel; Andreza F De Bem; Claudia F Benjamim; Fernanda G De Felice; Sergio T Ferreira; Julia R Clarke; Claudia P Figueiredo
Journal:  Mol Neurobiol       Date:  2016-12-13       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.